{
  "zip": "3000",
  "sector": "Healthcare",
  "longBusinessSummary": "Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering drugs for the treatment of patients with severe genetic and skin disorders worldwide. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity; and PRÃNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with EPP in the People's Republic of China. The company was founded in 1987 and is headquartered in Melbourne, Australia.",
  "city": "Melbourne",
  "phone": "61 3 9660 4900",
  "state": "VIC",
  "country": "Australia",
  "companyOfficers": [],
  "website": "http://www.clinuvel.com",
  "maxAge": 1,
  "address1": "535 Bourke Street",
  "fax": "61 3 9660 4909",
  "industry": "Biotechnology",
  "address2": "Level 11",
  "previousClose": 16.6,
  "regularMarketOpen": 16.829,
  "twoHundredDayAverage": 16.026403,
  "trailingAnnualDividendYield": 0.0009036144,
  "payoutRatio": 0.0764,
  "volume24Hr": null,
  "regularMarketDayHigh": 16.829,
  "navPrice": null,
  "averageDailyVolume10Day": 7512,
  "totalAssets": null,
  "regularMarketPreviousClose": 16.6,
  "fiftyDayAverage": 16.50909,
  "trailingAnnualDividendRate": 0.015,
  "open": 16.829,
  "averageVolume10days": 7512,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": 0.02,
  "exDividendDate": 1599177600,
  "beta": 0.390704,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 16.817,
  "priceHint": 2,
  "currency": "USD",
  "trailingPE": 85.36548,
  "regularMarketVolume": 1145,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 828260736,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 4653,
  "priceToSalesTrailing12Months": null,
  "dayLow": 16.817,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 1145,
  "fiftyTwoWeekHigh": 20.23,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 7.4,
  "bid": 0,
  "tradeable": false,
  "dividendYield": 0.0011,
  "bidSize": 0,
  "dayHigh": 16.829,
  "exchange": "PNK",
  "shortName": "CLINUVEL PHARMACEUTICALS LTD",
  "longName": "Clinuvel Pharmaceuticals Limited",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "CLVLY",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_6117181",
  "uuid": "7c5183a1-d7f1-3667-adec-c2ceb6cfdaaa",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0.51118,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 49410300,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.609,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1593475200,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": null,
  "trailingEps": 0.197,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 27.614119,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1656547200,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 35647088,
  "enterpriseValue": 820211584,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": 0.109,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 16.829,
  "logo_url": "https://logo.clearbit.com/clinuvel.com"
}